Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Greenwich Global Hedge Fund Index down 2.4% in August (-1.5% YTD) but continues to outperform world equity markets

Friday, September 09, 2011
Opalesque Industry Update – Hedge funds as measured by the Greenwich Global Hedge Fund Index (“GGHFI”) ended the month mostly lower in August, but continued to outperform world equity markets. The GGHFI declined 2.4% compared to global equity returns in the S&P 500 Total Return (-5.43%), MSCI World Equity (-7.26%), and FTSE 100 (-6.54%) equity indices. 29% of constituent funds in the GGHFI ended the month with gains.

Hedge Fund Strategy Highlights

• Directional Trading funds are the best performing group of funds in August, gaining 0.3%
• Market Neutral funds provide protection from market swings, declining only 2.9% on average for the month
• Long-Short Equity managers battle volatile markets during the month, losing 4.5%
• Short-Biased managers have their best month of the year, capitalizing on down markets to gain 9.1% in August
• Specialty Strategies group remains the best performer for the year, up 1.1%
• Developed Market funds proved to be a safer place than Emerging Market funds in August, losing only 2.1% on average compared to a loss of 5.5% for Emerging Market funds.

(press release)

Full performance table: http://www.greenwichai.com/index.php/returns-gai-global-hf-indices


Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its